Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models

In head and neck squamous cell cancer, the human epidermal growth factor receptor 1 (EGFR) is the dominant signaling molecule among all members of the family. So far, cetuximab is the only approved anti-EGFR monoclonal antibody used for the treatment of head and neck squamous cell cancer, but despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Burley, Thomas A., Da Pieve, Chiara, Martins, Carlos D., Ciobota, Daniela M., Allott, Louis, Oyen, Wim J.G, Harrington, Kevin J., Smith, Graham, Kramer-Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2019
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424230/
https://www.ncbi.nlm.nih.gov/pubmed/30213849
http://dx.doi.org/10.2967/jnumed.118.216069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424230/
https://www.ncbi.nlm.nih.gov/pubmed/30213849
http://dx.doi.org/10.2967/jnumed.118.216069

Ejemplares similares